In the evolving landscape of American healthcare, the Medicare Annual Wellness Visit (AWV) stands as a cornerstone of preventive strategy. Designed to transition senior care from reactive treatment to proactive health maintenance, the AWV was intended to serve as a comprehensive roadmap for long-term well-being. However, as the Centers for Medicare & Medicaid Services (CMS) evaluates the effectiveness of this program, a provocative question has emerged: Should the AWV remain a strictly physician-driven encounter, or is it time to leverage artificial intelligence (AI) to transform it into a continuous, data-driven experience?
This inquiry, positioned at the heart of the CMS proposed physician payment rule issued this summer, marks a potential paradigm shift in how millions of seniors interact with the healthcare system. As the agency nears its final ruling—expected around November 1—the debate has ignited a complex discussion involving technology developers, federal regulators, and the primary care physicians who serve as the gatekeepers of patient health.
The Problem with the Current AWV Model
The current AWV framework is a point-in-time assessment. It requires a patient to visit their physician to review health risk assessments, update medical histories, and screen for potential cognitive or physical declines. While the intention is noble, the empirical evidence regarding its success is, at best, inconclusive.
According to CMS, studies evaluating the AWV have yielded mixed results. While some data suggests that patients who receive these visits are more likely to utilize preventive services—such as vaccinations or cancer screenings—other studies indicate that the visits fail to significantly close gaps in care. Even more concerning, some research has suggested that the AWV may not correlate with improvements in acute care utilization or overall healthcare spending. In some instances, it may even inadvertently drive the utilization of low-value, downstream services, creating additional costs without tangible improvements in patient outcomes.
Stephanie Carlton, CMS’s deputy administrator and chief clinical AI officer, articulated the urgency of this situation at the recent Health Datapalooza conference in Washington, D.C. "Only about half the seniors use [the AWV]," Carlton noted. "And we don’t have good evidence that it’s actually resulting in better outcomes. That’s a huge opportunity for AI."
The AI Vision: From Snapshots to Continuous Care
The CMS vision for an "AI-driven" AWV is not intended to replace the human element entirely, but rather to augment the capabilities of the primary care team. The agency is exploring whether technology can shift the AWV from a static, once-a-year appointment to a dynamic, ongoing process.
Potential applications for clinical AI tools in this context include:
- Pre-visit Data Synthesis: Using AI to aggregate and analyze beneficiary-reported information, such as health risk assessments, well before the patient enters the office.
- Risk Stratification: Identifying high-risk beneficiaries who require immediate clinical intervention or specialized assessment, allowing doctors to prioritize their time more effectively.
- Actionable Insights: Generating personalized, evidence-based follow-up steps for clinicians to review and approve, thereby reducing the cognitive load on providers.
By integrating these tools, CMS hopes to create a preventive care function that is "more continuous, data-driven, and beneficiary-specific."
Regulatory Hurdles and the "Supervision" Question
Under current Medicare policy, the AWV is strictly regulated. It must be performed by a physician, or a team of medical professionals acting under the direct supervision of a physician enrolled as a Medicare provider. This "physician-in-the-room" requirement is a bedrock of accountability but also a significant barrier to the adoption of high-tech, third-party preventive models.
CMS has explicitly requested feedback on whether these requirements hinder the development of innovative models where technology companies—rather than traditional clinical practices—develop or operate clinical AI tools. The agency is particularly interested in whether these AI entities could affiliate with Medicare-enrolled providers to deliver these services more efficiently. This potential shift poses a fundamental question: Who owns the patient relationship when the "preventive care" is being mediated by an algorithm?
The AAFP Perspective: A Cautious Embrace
The American Academy of Family Physicians (AAFP), representing the clinicians who most frequently conduct these visits, has adopted a stance of "cautious positivity." In their official comment letter to CMS regarding the 2027 proposed payment rule, the AAFP acknowledged the potential for AI to alleviate the administrative burden that currently plagues primary care.
"AAFP supports the thoughtful use of AI to enhance Medicare AWVs," the academy stated in an email, noting that tools which summarize health information or identify care gaps can "give physician-led care teams more capacity to provide timely, coordinated preventive care."
However, the AAFP’s support comes with a significant caveat. The academy emphasizes that the AWV is not merely a checklist of screenings—it is a complex integration of a patient’s medical history, chronic conditions, behavioral health, and life circumstances.
The Importance of the "Trusted Relationship"
The core of the AAFP’s concern lies in the sanctity of the patient-physician relationship. In their view, the context required to make sound medical decisions is only available within an ongoing, trusted partnership. They argue that if CMS moves toward a model where technology vendors or AI companies independently furnish significant portions of preventive care, the system risks fragmenting the very care it aims to improve.
"We believe that technologies which improve access but undermine continuity, fragment care, or displace clinical accountability are inconsistent with the goals of primary care," the AAFP wrote.
Implications: Fragmentation vs. Innovation
The potential for "care fragmentation" is perhaps the most significant risk associated with the AI-driven AWV. If a third-party AI company is responsible for a patient’s preventive screening, while the primary care physician (PCP) handles the chronic disease management, the result could be:
- Inconsistent Recommendations: Different AI tools might offer conflicting guidance based on different datasets, leading to patient confusion.
- Duplicative Services: Without a central, human-led hub, tests may be ordered twice, or health information may be siloed, leading to redundant administrative work.
- Diluted Accountability: If a preventive screening is missed, who is responsible? The AI provider or the PCP?
The AAFP warns that the "disruption" of the primary care model could lead to a scenario where the patient is left with multiple, uncoordinated touchpoints rather than a unified health plan.
The Path Forward: November and Beyond
As the medical community awaits the final regulation from CMS, the industry is bracing for a new era of digital integration. The goal of the agency is clear: improve outcomes for a growing Medicare population while ensuring fiscal responsibility.
If CMS decides to relax the supervision requirements to allow for more robust AI integration, the move will likely be met with both excitement from the tech sector and defensive scrutiny from primary care advocates. The key to a successful transition, many experts suggest, will be a "human-in-the-loop" model. In this framework, AI handles the data processing, the predictive modeling, and the administrative burden, while the physician remains the final decision-maker—the architect of the patient’s care journey.
For the patients, the promise of an AI-enhanced AWV is compelling: a system that knows them better, predicts their needs before they arise, and keeps them healthier for longer. For the physicians, the challenge will be to ensure that these tools remain tools—not replacements for the human connection that serves as the foundation of medicine.
As we look toward the final rule in November, the conversation is no longer about if AI will play a role in the Medicare Annual Wellness Visit, but how it will be integrated without sacrificing the continuity and accountability that define the primary care experience. The outcome of this policy shift will likely set the tone for the future of digital health in the United States, balancing the cold, precise power of data with the warm, essential oversight of the family physician.
